Key result
Antihypertensive treatment compliance reaches only ~46%, with noncompliance linked to high costs and forgetfulness.
Why the study?
The study was conducted to assess the compliance of hypertensive patients to the treatment prescribed by their physician.
What is the rate of compliance to antihypertensive treatment among hypertensive patients, and what are the predictors of non-compliance?
Cross-Sectional (n=190)
No
What is the rate of compliance to antihypertensive treatment among hypertensive patients, and what are the predictors of non-compliance?
Absolute Event Rate: 46.31% vs 53.69%
More than half of hypertensive patients in this cohort were non-compliant to their medication, primarily driven by high cost and forgetfulness.
No takes yet. Share an insight, caveat, or question.
May inform adherence support targeting cost and forgetfulness; leaves open prospective evaluation of interventions.
Mustafa et al. (2025) conducted a cross-sectional in Hypertension (n=190). Antihypertensive treatment was evaluated on Compliance to antihypertensive drug treatment. Among hypertensive patients, only 46.31% were compliant with their antihypertensive treatment, with high cost (P=0.04) and forgetfulness (P=0.05) significantly predicting noncompliance.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: